Metabolites of progesterone and the pregnane X receptor: A novel pathway regulating uterine contractility in pregnancy?

doi:10.1016/j.ajog.2005.01.040

American Journal of Obstetrics and Gynecology

Volume 192, Issue 4, April 2005, Pages 1304-1313

https://doi.org/10.1016/j.ajog.2005.01.040 Get rights and content

Objective

The purpose of this study was to determine the role of 5β-dihydroprogesterone (5β-DHP), acting through the nuclear receptor pregnane X receptor (PXR), in regulating uterine contractility.

Study design

Uterine contractility was studied in tissues from women, rats, and mice. Messenger RNA was assessed using reverse transcriptase-polymerase chain reaction (RT-PCR), and protein was measured using enzyme assays, immunofluorescence microscopy, and Western analyses.

Results

Human and rat uterine tissues contain mRNA and protein for 5β-reductase and for PXR. Acute in vitro treatment with 5β-DHP causes rapid uterine relaxation that is not mediated by PXR. Chronic in vivo administration of 5β-DHP to mice with intact PXR, but not in mice with disrupted PXR, causes an increased effect of 1400W, a specific inhibitor of inducible nitric oxide synthase (iNOS). This suggests that 5β-DHP increased iNOS-modulated uterine tone, as occurs during pregnancy.

Conclusion

These data support the hypothesis that metabolites of progesterone may act chronically through a PXR-mediated mechanism to regulate uterine contractility.

Section snippets

Tissue collection

All protocols for human tissue collection were approved by the University of Alberta Human Ethics Review Board. Uterine samples were obtained from hysterectomy specimens from women undergoing surgery for non-neoplastic and noninflammatory indications. Human liver and kidney samples were obtained through the Department of Pathology at the University of Alberta Hospital with patient permission. The human lower segment myometrium, placenta, fetal membranes, and umbilical cord tissues were obtained

Results

Our first question was whether reproductive tissues had the capacity to form 5β-reduced metabolites of P4. Using nonquantitative RT-PCR, we demonstrated the presence of mRNA for 5β-reductase in human liver and kidney, as well as several reproductive tissues, including fetal membranes, decidua, placenta, myometrium, and umbilical vessels (Figure 1A). Using a radiolabel enzyme assay, we also detected 5β-reductase activity in a variety of reproductive and nonreproductive tissues of human and mouse

Comment

These data provide information about a potentially important pathway that may influence uterine contractility. We have demonstrated the presence of the enzyme necessary to produce 5β-reduced metabolites of P4 within human and rat uterine tissues. We also have demonstrated the presence of mRNA and protein for PXR on myometrial and endometrial cells from both human and mouse uterus. Further, we have provided evidence that treatment of PXR+/+ mice with 5β-DHP increases iNOS-mediated suppression of

Acknowledgments

We acknowledge the assistance of Dr Glen Baker and Gail Rauw from the University of Alberta Neurochemical Research Unit, who performed the HPLC-MS assays for serum 5β-DHP, and to Dr Xin Fang for assistance with the Western analyses. We also are grateful to Capital Health and the Obstetrical staff of the Royal Alexandra Hospital for collection of the human myometrial samples, and to the staff of the University of Alberta Health Sciences Laboratory Animal Services for their excellent care of the

References (36)

S. Csabina et al.
Stretch-induced myosin light chain phosphorylation in rat uterus
Arch Biochem Biophys
(1986)
Y. Manabe et al.
Fetal viability does not affect the onset of stretch-induced labor and the increase in amniotic fluid prostaglandin F2 alpha and plasma prostaglandin F2 alpha metabolite levels
Prostaglandins
(1992)
D. Tulchinsky et al.
Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. 1. Normal pregnancy
Am J Obstet Gynecol
(1972)
R. Cabral et al.
Progesterone and pregnanolone derivatives relaxing effect on smooth muscle
Gen Pharmacol
(1994)
M. Perusquia et al.
Influence of 5alpha- and 5beta-reduced progestins on the contractility of isolated human myometrium at term
Life Sci
(2001)
C. Kubli-Garfias
Modulatory action of 5-reduced androgens and progestins on the excitability of CNS and smooth muscle
J Steroid Biochem
(1987)
S.A. Kliewer et al.
An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway
Cell
(1998)
A. Charbonneau et al.
Genomic organization of a human 5beta-reductase and its pseudogene and substrate selectivity of the expressed enzyme
Biochim Biophys Acta
(2001)
E.P. Garvey et al.
1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo
J Biol Chem
(1997)
M. Rossato et al.
Identification of functional binding sites for progesterone in rat Leydig cell plasma membrane
Steroids
(1999)

K. Burger et al.

Non-genomic effects of progesterone on the signaling function of G protein-coupled receptors

FEBS Lett

(1999)

S.J. Lye et al.

Role of mechanical signals in the onset of term and preterm labor

Front Horm Res

(2001)

J.R.G. Challis et al.

Parturition

N.S. Wood et al.

Neurologic and developmental disability after extremely preterm birth. EPICure Study Group

N Engl J Med

(2000)

Arbuckle T DS, Liu S, Rouleau J, Rusen ID, Turner L, Wen SW. Canadian Perinatal Health Report: Health Canada;...

J.R.G. Challis et al.

Endocrine and paracrine regulation of birth at term and preterm

Endocr Rev

(2000)

M. Lofgren et al.

Serum concentrations of progesterone and 5 alpha-pregnane-3,20-dione during labor and early post partum

Acta Obstet Gynecol Scand

(1990)

G. Bertilsson et al.

Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction

Proc Natl Acad Sci U S A

(1998)

Cited by (36)

The A-ring reduction of 11-ketotestosterone is efficiently catalysed by AKR1D1 and SRD5A2 but not SRD5A1
2020, Journal of Steroid Biochemistry and Molecular Biology
Citation Excerpt :
The AKR1D1-catalysed 5β-reduction of T yields 5β-dihydroxytestosterone (5β-DHT), a metabolite that has no androgenic activity due to the induction of a conformational change in the A/B-ring that hinders binding to the AR [32,33]. AKR1D1 is primarily expressed in the liver [34–37] were it competes with SRD5A isoforms for 3-keto-Δ4 steroid substrates [21,24]. The relative expression levels and activity of these enzymes will therefore determine the ratio of 5α- and 5β-reduced products.
Testosterone and its 5α-reduced form, 5α-dihydrotestosterone, were previously thought to represent the only active androgens in humans. However, recent studies have shown that the potent androgen, 11-ketotestosterone, derived from the adrenal androgen precursor, 11β-hydroxyandrostenedione, may in fact serve as the primary androgen in healthy women. Yet, despite recent renewed interest in these steroids, their downstream metabolism has remained undetermined. We therefore set out to investigate the metabolism of 11-ketotestosterone by characterising the 5α- or 5β-reduction commitment step. We show that inactivation of 11-ketotestosterone is predominantly driven by AKR1D1, which efficiently catalyses the 5β-reduction of 11-ketotestosterone, committing it to a metabolic pathway that terminates in 11-ketoetiocholanolone. We demonstrate that 5α-reduction of 11-ketotestosterone is catalysed by SRD5A2, but not SRD5A1, and terminates in 11-ketoandrosterone, but is only responsible for a minority of 11-ketotestosterone inactivation. However, as 11-ketoetiocholanolone is also generated by the metabolism of the glucocorticoid cortisone, 11-ketoandrosterone should be considered a more specific urinary marker of 11-ketotestosterone production.
Occurrence and mass balance of sixty-two progestins in a municipal sewage treatment plant
2019, Water Research
Citation Excerpt :
In addition, relatively high concentrations of 5β-DHP (120 ± 27 ng/L) and 3α,5β-THP (107 ± 12 ng/L) were first observed in the STP wastewater. 5β-DHP is an agonist of the pregnane X receptor, regulating uterine contractility through activation of the receptor (Mitchell et al., 2005; Hagedorn et al., 2007). 3α,5β-THP is a positive allosteric modulator of the GABAA receptor and a negative allosteric modulator of the glycine receptor, having anticonvulsant, anesthetic, anxiolytic, and sedative effects (Reddy, 2003).
Progestins (PGs) are a group of steroid hormones known to have endocrine-disrupting effects. These compounds can enter the aquatic environment via the discharge of treated or untreated wastewater and the disposal of sludge from sewage treatment plants (STPs); thus, their removal in STPs are of great importance. The present study simultaneously investigated the occurrences and fates of 62 PGs in a municipal STP in Beijing, China. Progesterone (P) and its metabolites were found to be the predominant compounds, with total dissolved concentrations of 1866 ng/L in the influent. About 11 P metabolites were newly detected, accounting for 25–55% and 75–91% of the total concentrations in wastewater and sludge, respectively. For the other three groups of PGs derived from different parent compounds, P derivatives were first detected in the STP with the highest concentration in the wastewater and sludge, followed by 19-nortestosterone (NT) derivatives and 17α-hydroxyprogesterone (17α-OHP) derivatives. The removal efficiencies in the dissolved phase of wastewater were relatively high for P and its metabolites (95–99%) and P derivatives (91–99%). And the relative persistence of NT (68–99%) and 17α-OHP derivatives (79–99%) was observed during the wastewater treatment processes. Mass balance analysis showed that the lost mass proportions were as high as 41–99%, the mass fractions in sludge were in the range of 0–55%, and 0.24–25% of the initial mass loadings was present in the effluent. These results indicated that biodegradation was the major removal mechanism of PGs in the STP.
Retinoic acid signaling determines the fate of the uterus from the mouse Müllerian duct
2019, Reproductive Toxicology
In female mice, the Müllerian duct develops into the oviduct, uterus and vagina. The fate of epithelia is determined by factors secreted from the mesenchyme. Retinoic acid (RA) and its receptors are present in the mesenchyme of cranial Müllerian duct. RA induces Müllerian duct to uterine epithelial differentiation whereas inhibition of RA receptors induces vaginal epithelial differentiation. Thus, RA signaling in the Müllerian duct is required to promote differentiation of the mesenchyme into the future uterus. Perinatal estrogen exposure induces various abnormalities in Müllerian duct-derived organs. These include a cranial shift of the border among oviduct, uterus and vagina as well as precancerous lesions suppressed by co-treatment with RA and estrogen. Since RA synthesis enzymes and receptors are expressed both in the epithelium and stroma after birth, RA signaling may act in the epithelia to maintain adult epithelial homeostasis and to prevent irreversible lesions induced by perinatal estrogen exposure.
Contractile effect of rifaximin on bovine uterus in the presence of steroid hormone antagonists
2018, Theriogenology
Citation Excerpt :
In the presence of tamoxifen or mifepristone, rifaximin induced a tonic effect on contractility. We believed that the antibiotic could bind with the pregnane X receptor (PXR) [22–25]. This receptor can be impaired by the co-activation of steroids and rifaximin, which delays the potentiation of the contractant/releasing activity exercised by the steroid hormones predominant at different stages of the cycle [7].
This in vitro study investigated the modulatory effect of rifaximin on bovine uterus contractility, in both phases of the oestrous cycle, with and without the steroid hormones that are predominant in the respective phases: oestrogen in the follicular phase and progesterone in the luteal phase. The procedures were conducted in an isolated organ bath by using rifaximin alone (10⁻⁴ M) and in association with the steroid hormone antagonists (10⁻⁵ M) tamoxifen (oestrogen antagonist) in the follicular phase and mifepristone (progesterone antagonist) in the luteal phase. The results indicated that rifaximin can stimulate uterine contractility. Indeed, the administration of rifaximin in the presence of tamoxifen or mifepristone increased the tonic activity of the uterus in both phases of the cycle. This result is clinically significant because rifaximin might also enable, in vivo, a simultaneous increase in uterine cleaning and the antimicrobial action against bacteria during the first 14 days postpartum, during the development of acute metritis.
Modulatory effect of three antibiotics on uterus bovine contractility invitro and likely therapeutic approaches in reproduction
2014, Theriogenology
This in vitro study investigates the modulatory effect of three antibiotics (amoxicillin, enrofloxacin, and rifaximin) on contractility of the bovine uterine tissue in follicular and luteal phases. The effects of these antibiotics at three single doses (10⁻⁶, 10⁻⁵, and 10⁻⁴ M) on their basal contractility were evaluated in isolated organ bath. The functionality of the strip throughout the experiment was evaluated by a dose of carbachol (10⁻⁵ M); the obtained effect had to be repeatable (difference of ≤20%) that is comparable to that induced by the previous administration of the same substance. The results demonstrate the different modulatory activities of these antibiotics on uterine contractility in follicular and luteal phases. The effects induced by amoxicillin and enrofloxacin are opposite: the first relaxes and the second increases the uterine contractility in both cycle phases. Instead, the activity of rifaximin varies depending on the phase of estrous cycle: it increases in the follicular phase and relaxes in the luteal phase. The obtained data provide the hypothesis of possible implications of these drugs in the pharmacologic modulation of uterine contractions. Their action at this level, associated with their specific antimicrobial effects, could suggest using these antibiotics for the treatment of diseases related to postpartum or infections that may occur in pregnant cattle, by virtue of their effects on myometrial contractility too.
5β-Reduced steroids and human Δ<sup>4</sup>-3-ketosteroid 5β-reductase (AKR1D1)
2014, Steroids
Citation Excerpt :
Interestingly, plasma 5β-pregnane concentrations or the 5β-pregnane/progesterone ratio decreases during late pregnancy until post-partum [53,56,57] with a concurrent decrease in 5β-reductase expression in the uterus [53]. The mechanism through which the 5β-pregnanes exert the tocolytic effect remains controversial, and possibly involves PXR [58], the GABAA receptor [59], calcium signaling [60,61], and the oxytocin receptor [62,63]. 5β-Pregnanes are involved in erythropoiesis in birds [40], rodents [64], and primates [65] and have also been reported to stimulate the growth of erythroid progenitor cells in human [41].
5β-Reduced steroids are non-planar steroids that have a 90° bend in their structure to create an A/B cis-ring junction. This novel property is required for bile-acids to act as emulsifiers, but in addition 5β-reduced steroids have remarkable physiology and may act as potent tocolytic agents, endogenous cardiac glycosides, neurosteroids, and can act as ligands for orphan and membrane bound receptors. In humans there is only a single 5β-reductase gene AKR1D1, which encodes Δ⁴-3-ketosteroid-5β-reductase (AKR1D1). This enzyme is a member of the aldo–keto reductase superfamily, but possesses an altered catalytic tetrad, in which Glu120 replaces the conserved His residue. This predominant liver enzyme generates all 5β-dihydrosteroids in the C₁₉–C₂₇ steroid series. Mutations exist in the AKR1D1 gene, which result in loss of protein stability and are causative in bile-acid deficiency.

View all citing articles on Scopus

Supported by grants from the Heart and Stroke Foundation of Canada, the Canadian Institutes of Health Research (Institute of Human Development, Child and Youth Health), and The Alberta Heritage Foundation for Medical Research.

Presented at the 23rd Annual Meeting of the American Gynecological and Obstetrical Society, September 9-11, 2004, Bolton Landing, NY.

View full text

Transactions from the Annual Meeting of the American Gynecological and Obstetrical SocietyMetabolites of progesterone and the pregnane X receptor: A novel pathway regulating uterine contractility in pregnancy?

Objective

Study design

Results

Conclusion

Section snippets

Tissue collection

Results

Comment

Acknowledgments

Arch Biochem Biophys

Prostaglandins

Am J Obstet Gynecol

Gen Pharmacol

Life Sci

J Steroid Biochem

Cell

Biochim Biophys Acta

J Biol Chem

Steroids

FEBS Lett

Role of mechanical signals in the onset of term and preterm labor

Front Horm Res

Parturition

Neurologic and developmental disability after extremely preterm birth. EPICure Study Group

N Engl J Med

Endocrine and paracrine regulation of birth at term and preterm

Endocr Rev

Serum concentrations of progesterone and 5 alpha-pregnane-3,20-dione during labor and early post partum

Acta Obstet Gynecol Scand

Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction

Proc Natl Acad Sci U S A

Transactions from the Annual Meeting of the American Gynecological and Obstetrical Society
Metabolites of progesterone and the pregnane X receptor: A novel pathway regulating uterine contractility in pregnancy?